SCHEMBL5607134

SCHEMBL5607134

CCOC(=Cc1ccc(OCc2ccccc2)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.67
ALDH1A1 P00352 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
LMNA P02545 1/20 0.50
KDM4E B2RXH2 3/20 0.47
MAPT P10636 2/20 0.47
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
NPC1 O15118 1/20 0.47
GAA P10253 1/20 0.47
RAB9A P51151 1/20 0.47
GSK3B P49841 2/20 0.47
BACE1 P56817 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
PTPN1 P18031 1/20 0.45
LTA4H P09960 1/20 0.45
MAOB P27338 2/20 0.45
ALOX5 P09917 1/20 0.44
NR4A1 P22736 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607131 1.00 NR1H4 (0.67) NR1H4ALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL5607288 0.91 NR1H4 (0.58) NR1H4ALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL5607287 0.91 NR1H4 (0.58) NR1H4ALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL5606686 0.90 NR1H4 (0.57) NR1H4ALDH1A1L3MBTL1KDM4EMAPT
SCHEMBL5606690 0.90 NR1H4 (0.57) NR1H4ALDH1A1L3MBTL1KDM4EMAPT
SCHEMBL2807676 0.89 NR1H4 (0.79) NR1H4ALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL2804643 0.89 NR1H4 (0.79) NR1H4ALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL2804642 0.89 NR1H4 (0.79) NR1H4ALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL5606735 0.88 NR1H4 (0.56) NR1H4ALDH1A1L3MBTL1KDM4EMAPT
SCHEMBL5606731 0.88 NR1H4 (0.56) NR1H4ALDH1A1L3MBTL1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR NR1H4 220/4885ALDH1A1 5/4885L3MBTL1 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.